[36kr] 中信证券:中国创新药产业有望迎来管线潜力的验证与价值提升

Available in: 中文
2026-04-23T00:36:31.146Z·1 min read
Originally published in Chinese on 36kr.

中信证券:中国创新药产业有望迎来管线潜力的验证与价值提升

Source

Originally published in Chinese on 36kr.

Read the full article: 中信证券:中国创新药产业有望迎来管线潜力的验证与价值提升

↗ Original source · 2026-04-23T00:00:00.000Z
← Previous: [36kr] 三星电子3.7万工人将举行集会,为下月罢工做准备Next: [36kr] 软银寻求以OpenAI股份为担保,获取100亿美元保证金贷款 →
Comments0